UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 660

Sortiert nach

Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types

PLoS genetics, 2013-04, Vol.9 (4), p.e1003464-e1003464

2013

Volltextzugriff (PDF)

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma

Proceedings of the National Academy of Sciences - PNAS, 2011-03, Vol.108 (11), p.4453-4458

2011

Volltextzugriff (PDF)

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas

Expert review of vaccines, 2012-02, Vol.11 (2), p.133-144

2012

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Variant III Contributes to Cancer Stem Cell Phenotypes in Invasive Breast Carcinoma

Cancer research (Chicago, Ill.), 2012-05, Vol.72 (10), p.2657-2671

2012

Volltextzugriff (PDF)

Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas

Journal of neuro-oncology, 2012-07, Vol.108 (3), p.395-402

2012

Volltextzugriff (PDF)

Development of an EGFRvIII specific recombinant antibody

BMC biotechnology, 2010-10, Vol.10 (1), p.72-72, Article 72

2010

Volltextzugriff (PDF)

The Scaffolding Adapter Gab1 Mediates Vascular Endothelial Growth Factor Signaling and Is Required for Endothelial Cell Migration and Capillary Formation

The Journal of biological chemistry, 2007-03, Vol.282 (11), p.7758-7769

2007

Volltextzugriff (PDF)

C-jun NH2-terminal kinase 2α2 promotes the tumorigenicity of human glioblastoma cells

Cancer research (Chicago, Ill.), 2006-10, Vol.66 (20), p.10024-10031

2006

Volltextzugriff (PDF)

Constitutive Activity of JNK2α2 Is Dependent on a Unique Mechanism of MAPK Activation

The Journal of biological chemistry, 2008-12, Vol.283 (50), p.34935-34945

2008

Volltextzugriff (PDF)

The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas

Neurosurgery clinics of North America, 2010, Vol.21 (1), p.87-93

2010

Volltextzugriff (PDF)

Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III

Cancer research (Chicago, Ill.), 2014-02, Vol.74 (4), p.1238-1249

2014

Volltextzugriff (PDF)

Proteolytic Cleavage of the CD44 Adhesion Molecule in Multiple Human Tumors

The American journal of pathology, 2002-02, Vol.160 (2), p.441-447

2002

Volltextzugriff (PDF)

Gab1 Is an Integrator of Cell Death versus Cell Survival Signals in Oxidative Stress

Molecular and Cellular Biology, 2003-07, Vol.23 (13), p.4471-4484

2003

Volltextzugriff (PDF)

Expression of constitutively activated EGFrvIII in non-small cell lung cancer

Cancer science, 2003-01, Vol.94 (1), p.50-56

2003

Volltextzugriff (PDF)

Grb2-Associated Binder-1 Mediates Phosphatidylinositol 3-Kinase Activation and the Promotion of Cell Survival by Nerve Growth Factor

Proceedings of the National Academy of Sciences - PNAS, 1997-11, Vol.94 (23), p.12419-12424

1997

Volltextzugriff (PDF)

Elevated JNK activation contributes to the pathogenesis of human brain tumors

Oncogene, 2002-08, Vol.21 (33), p.5038-5046

2002

Volltextzugriff (PDF)

Development and Evaluation of a Web-Based Resource for Suicidal Thoughts: NowMattersNow.org

Journal of medical Internet research, 2019-05, Vol.21 (5), p.e13183-e13183

2019

Volltextzugriff (PDF)

Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody

Artificial cells, nanomedicine, and biotechnology, 2018-02, Vol.46 (1), p.89-94

2018

Volltextzugriff (PDF)

EGF receptor variant III as a target antigen for tumor immunotherapy

Expert review of vaccines, 2008-09, Vol.7 (7), p.977-985

2008

Volltextzugriff (PDF)

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma

Journal of hematology and oncology, 2013-05, Vol.6 (1), p.33-33, Article 33

2013

Volltextzugriff (PDF)

Generation of regulable EGFRvIII targeted chimeric antigen receptor T cells for adoptive cell therapy of glioblastoma

Biochemical and biophysical research communications, 2018-12, Vol.507 (1-4), p.59-66

2018

Volltextzugriff (PDF)

Proteolytic Release of CD44 Intracellular Domain and Its Role in the CD44 Signaling Pathway

The Journal of cell biology, 2001-11, Vol.155 (5), p.755-762

2001

Volltextzugriff (PDF)

The Tyrosine Phosphatase SHP-2 Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase

Molecular and Cellular Biology, 2000-11, Vol.20 (22), p.8513-8525

2000

Volltextzugriff (PDF)

A Grb2-associated docking protein in EGF- and insulin-receptor signalling

Nature (London), 1996-02, Vol.379 (6565), p.560-564

1996

Volltextzugriff (PDF)

Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor

The Journal of biological chemistry, 1998-01, Vol.273 (1), p.200-206

1998

Volltextzugriff (PDF)

1 – 25 von 660

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(594)
Mit Volltextzugriff
(568)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(476)
Life Sciences & Biomedicine
(381)
Humans
(351)
Female
(189)
Male
(189)
Biological And Medical Sciences
(133)
Animals
(112)
Middle Aged
(108)
Medical Sciences
(103)
Adult
(101)
Aged
(85)
Mice
(56)
Biochemistry & Molecular Biology
(53)
Science & Technology - Other Topics
(49)
Neurosciences & Neurology
(48)
Multidisciplinary Sciences
(46)
Oncology
(46)
Technology
(43)
Neurosciences
(42)
Aged, 80 And Over
(39)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas

Epidermal Growth Factor Receptor Variant III Contributes to Cancer Stem Cell Phenotypes in Invasive Breast Carcinoma

Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas

Development of an EGFRvIII specific recombinant antibody

The Scaffolding Adapter Gab1 Mediates Vascular Endothelial Growth Factor Signaling and Is Required for Endothelial Cell Migration and Capillary Formation

C-jun NH2-terminal kinase 2α2 promotes the tumorigenicity of human glioblastoma cells

Constitutive Activity of JNK2α2 Is Dependent on a Unique Mechanism of MAPK Activation

The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas

Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III

Proteolytic Cleavage of the CD44 Adhesion Molecule in Multiple Human Tumors

Gab1 Is an Integrator of Cell Death versus Cell Survival Signals in Oxidative Stress

Expression of constitutively activated EGFrvIII in non-small cell lung cancer

Grb2-Associated Binder-1 Mediates Phosphatidylinositol 3-Kinase Activation and the Promotion of Cell Survival by Nerve Growth Factor

Elevated JNK activation contributes to the pathogenesis of human brain tumors

Development and Evaluation of a Web-Based Resource for Suicidal Thoughts: NowMattersNow.org

Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody

EGF receptor variant III as a target antigen for tumor immunotherapy

Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma

Generation of regulable EGFRvIII targeted chimeric antigen receptor T cells for adoptive cell therapy of glioblastoma

Proteolytic Release of CD44 Intracellular Domain and Its Role in the CD44 Signaling Pathway

The Tyrosine Phosphatase SHP-2 Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase

A Grb2-associated docking protein in EGF- and insulin-receptor signalling

Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor

Suchergebnisse filtern